Delivery Order SPE2DB25D2204-SPE2DB25FTHBJ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,714.19 to AmerisourceBergen Drug Corp for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets (500 count) with a firm fixed price and completion date of August 27, 2025. This non-set-aside competitive award was made to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor and healthcare solutions provider. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets in quantities of 100 units. This is a competitively awarded, firm fixed price contract with no set-aside designation, valued at $1,474.20 and scheduled for completion by August 29, 2025. The product will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets in quantities of 100 units, with a contract ceiling value of $1,228.50. This delivery order represents a firm fixed-price transaction with no set-aside designation, indicating competitive award. The contract is classified as a child action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,010.60 to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets (100 count) on July 29, 2025, with completion scheduled for July 30, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,516.31 to AmerisourceBergen Drug Corp for Butalbital-Aspirin-Caffeine tablets (90-count) on August 18, 2025, with completion scheduled for August 19, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at the company's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor, serves as a prime...
- The Defense Logistics Agency awarded a delivery order valued at $2,538.79 to AmerisourceBergen Drug Corp for the supply of Butalbital-Acetaminophen-Caffeine 50-300-40mg tablets in a quantity of 100 units. This non-competitive, firm fixed-price delivery order was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award...
- The Defense Logistics Agency awarded a $1,258.58 delivery order to AmerisourceBergen Drug Corp for Butalbital-Acetaminophen-Caffeine 50-325-40 mg tablets (500 count) on July 31, 2025, with completion expected by August 1, 2025. This firm fixed price, competitively awarded delivery order represents a non-set-aside procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $9,373.17 to AmerisourceBergen Drug Corp for butalbital-acetaminophen-caffeine 50-325-40mg tablets (100 count) on July 29, 2025, with an ultimate completion date of July 30, 2025. This non-set-aside, competitively awarded contract was issued under firm fixed-price terms and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The product being supplied is a combination pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,032.63 to AmerisourceBergen Drug Corp for Butalbital-Aspirin-Caffeine 90-count tablets, with an ultimate completion date of August 5, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement issued on August 4, 2025, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,088.32 to AmerisourceBergen Drug Corp for 100 capsules of ASA-Butalbital-Caffeine compound (ASA-BUTALB-CAFF-COD) on September 23, 2025, with completion scheduled for September 24, 2025. This competitively awarded, firm fixed-price delivery order was placed without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The order represents a child contract action under...
- SPE2DB25D2204Indefinite Delivery Contract
- SPE2DB25D2204-SPE2DB25FTHBJDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,722.57 to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Butalbital-Acetaminophen-Caffeine 50-325-40mg tablets (500 count). This firm fixed price, non-set-aside contract is scheduled for completion by September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction within the company's broader pharmaceutical supply relationship with the federal government. This award is issued as a child contract under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications, vaccines, and medical commodities to support military healthcare systems worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's consistent receipt of competitively awarded, non-set-aside contracts demonstrates its capability to meet federal pharmaceutical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 9/23/25 |